2020 annual financial data

Scinai Immunotherapeutics 2020 Net margin

Direct answer

Net margin was Not calculable.

Operating income was 2,282,000 USD and net income was -1,386,000 USD.
Operating cash flow was -22,568,992 USD.

Get free Scinai Immunotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
2,282,000 USD
Net income
-1,386,000 USD
Operating cash flow
-22,568,992 USD